Silence Therapeutics Plc (SLN) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Silence Therapeutics Plc Company Snapshot

Business Description:

Silence Therapeutics Plc operates in the Commercial physical research sector. Silence Therapeutics plc (Silence) is a biotechnology research and development company. Silence, along with its subsidiaries, is engaged in research and development of pharmaceutical products. The Company discovers, develops and delivers ribonucleic acid (RNA) interference (RNAi) therapeutics for the treatment of serious diseases. Silence operates two segments: RNAi therapeutics and Immunotherapy. Teh Company's product pipeline includes PF-4523655 (AtuRNAi), QPI-1002 (AtuRNAi), QPI-1002 (AtuRNAi), Atu134 (AtuRNAi), Atu111 (AtuRNAi) and Atu195 (AtuRNAi). Its subsidiaries include Silence Therapeutics AG, Intradigm Corporation and Stanford Rook Ltd. On January 5, 2010, the Company and Intradigm Corporation announced that the companies have completed their merger. In our complete report available for purchase the company is compared to: Proximagen Group Plc, Cyprotex PLC and Phytopharm plc.

Silence Therapeutics Plc

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 2.85p
(Figures in Pounds Sterling)

1 Week	0.0%	13 Weeks	18.5%

4 Weeks	5.6%	52 Weeks	-56.5%

Silence Therapeutics Plc Key Data:

Ticker:	SLN	Country:	UNITED KINGDOM

Exchanges:	LON	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Diversified Drugs, Cosmetics, & Health Care

2010 Sales	2,365,877 (Year Ending Jan 2011).	Employees:	49

Currency:	Pounds Sterling	Market Cap:	16,432,644

Fiscal Yr Ends:	December	Shares Outstanding:	576,584,000

Share Type:	Ordinary	Closely Held Shares:	1,176,714

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.